Prescription of anti-rheumatic drugs should be by approved name because in most cases differences in absorption can be compensated by titration of dosage against effectiveness and toxicity. There are a few instances, for example phenylbutazone, where known differences of bio-availability justify the use of a particular brand.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.